News

Detection of Gene Mutations in Tampons of Patients With Hig...

Detection of Gene Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer

October 14, 2014

(October 14, 2014) In a pilot study published in the journal Obstetrics & Gynecology, researchers detected DNA derived from tumor cells in the vaginas of 60% of patients with ovarian cancer with intact fallopian tubes. With further development, this approach may hold promise for the early detection of this deadly disease. Click here to read … Continued

Research

Ovarian Cancer Oncogene Found in ‘Junk DNA’

Ovarian Cancer Oncogene Found in ‘Junk DNA’

October 6, 2014

(October 6, 2014) A research team based at the University of Pennsylvania mined junk DNA sequences to identify a non-protein-coding RNA whose expression is linked to ovarian cancer.  The study, which was published in Cancer Cell, was supported in part by an OCRF research grant to Lin Zhang, MD. The researchers built a DNA copy … Continued

Research

Partner Member Profile: Lilies of the Valley

Partner Member Profile: Lilies of the Valley

September 29, 2014

Lilies of the Valley got its start in 2004 when a new gynecologic oncologist moved to the city of Huntsville, Alabama. His wife had a friend with ovarian cancer, and she noticed that there were no support groups available for women with this disease. Current Executive Director Regina Parker recalls: “She got together with some … Continued

Community

SGO Perspectives on Endpoints for Studies of Ovarian Cancer

SGO Perspectives on Endpoints for Studies of Ovarian Cancer

September 29, 2014

(Sept. 29, 2014) In a perspective piece for the website MedPage Today, representatives from the Society of Gynecologic Oncology discuss clinical endpoints appropriate for studies addressing the “unique characteristics” of ovarian cancer and progress toward improving outcomes for women affected by the disease. In the article, co-authors Thomas J. Herzog, MD, of the University of Cincinnati … Continued

Research

Maintenance Pazopanib in Ovarian Cancer: No Survival Benefi...

Maintenance Pazopanib in Ovarian Cancer: No Survival Benefit, High Rate of Complications

September 25, 2014

(Sept. 25, 2014) Maintenance therapy with the oral agent pazopanib improved progression free survival (PFS) by a median of 5.6 months in patients with advanced ovarian cancer but did not impact overall survival, according to the results of a phase III randomized trial reported in the Journal of Clinical Oncology. In this clinical trial, which … Continued

Research

OCRF Research Finds Metastasis Promoted by Mesothelial Cells

OCRF Research Finds Metastasis Promoted by Mesothelial Cells

September 19, 2014

A new study in the Journal of Clinical Investigation indicates that mesothelial cells actively promote the spread of ovarian cancer. Using a three dimensional culture model of ovarian cancer metastasis, OCRF grantee and Scientific Advisory Committee Member Ernst Lengyel, MD, PhD, and colleagues at the Unviersity of Chicago found that in the presence of cancer … Continued

OCRA News

Call for Ideas Now Open for the Ovarian Cancer Translationa...

Call for Ideas Now Open for the Ovarian Cancer Translational Research Dream Team Grant

September 18, 2014

A Collaboration of Stand Up To Cancer, Ovarian Cancer Research Fund, Ovarian Cancer National Alliance and National Ovarian Cancer Coalition PHILADELPHIA — The American Association for Cancer Research (AACR) is now accepting submissions of ideas for the Stand Up To Cancer (SU2C)-Ovarian Cancer Research Fund (OCRF)-Ovarian Cancer National Alliance (OCNA)-National Ovarian Cancer Coalition (NOCC) Translational … Continued

OCRA News

Ovarian Cancer Dream Team Call for Ideas Now Open

Ovarian Cancer Dream Team Call for Ideas Now Open

September 18, 2014

The American Association for Cancer Research is now accepting submissions of ideas for the new Stand Up To Cancer Ovarian Cancer Translational Research Dream Team Grant that will offer up to $6 million in research funding, which includes $3 million provided by the leading funder, OCRF. The Stand Up To Cancer-Ovarian Cancer Research Fund-Ovarian Cancer … Continued

Research

New Study Shows No Association between Powder Use and Ovari...

New Study Shows No Association between Powder Use and Ovarian Cancer

September 12, 2014

(September 12, 2014) A new study published in the Journal of the National Cancer Institute this month suggests that use of perineal powder does not influence ovarian cancer risk. In the past, some studies have suggested that there is an increased risk of ovarian cancer among talc users.  In this new and large prospective study, … Continued

Research

New Stand Up To Cancer Ovarian Cancer Dream Team Announced

New Stand Up To Cancer Ovarian Cancer Dream Team Announced

September 5, 2014

Ovarian Cancer Community Joins Forces to Fight Deadliest Gynecologic Cancer A groundbreaking collaboration among three national ovarian cancer organizations was announced during the Stand Up to Cancer telecast on Friday evening, September 5th. Ovarian Cancer Research Fund (OCRF), Ovarian Cancer National Alliance (OCNA), and National Ovarian Cancer Coalition (NOCC) have teamed up with Stand Up … Continued

OCRA News

Where There’s a Wheel, There’s a Way: Ovarian C...

Where There’s a Wheel, There’s a Way: Ovarian Cycle Founder, Bethany Diamond

September 5, 2014

From one ride in 2004, to a national event in 2014.

Community

Ovarian Cancer Research Fund and National Sponsor QVC Expan...

Ovarian Cancer Research Fund and National Sponsor QVC Expand Woman to Woman Program

September 3, 2014

Gynecologic Cancer Patients to Receive New Support in Los Angeles, CA; Pittsburgh, PA; Stony Brook, NY and Chicago, IL WEST CHESTER, Pa (September 3, 2014) —Ovarian Cancer Research Fund (OCRF) and QVC today announced four new Woman to Woman grant recipients: City of Hope in Los Angeles, CA; Magee-Womens Hospital of University of Pittsburgh Medical … Continued

OCRA News